Big news for our European patients and physicians! AtriClip Left Atrial Appendage Exclusion Systems are now indicated for use in patients at high risk of thromboembolism for whom LAAE is warranted. Deployed in more than 550,000 cases worldwide, we're excited to witness the significant impact our devices are making on patient care.

Read on to learn more: <a href="https://okt.to/KhDyQR&quot; target="_blank">https://okt.to/KhDyQR</a&gt;

Happy 4th of July! Celebrating the freedom and independence that shaped our nation. <a href="https://twitter.com/hashtag/IndependenceDay?src=hashtag_click&quot; target="_blank">#IndependenceDay</a> <a href="https://twitter.com/hashtag/FourthOfJuly?src=hashtag_click&quot; target="_blank">#FourthOfJuly</a>

Excited to be part of the <a href="https://twitter.com/CincyMuseum&quot; target="_blank">@CincyMuseum</a>'s new Advancing Health Exhibit. Grateful for AtriCure’s opportunity to sponsor the heart health segment and raise awareness of Atrial Fibrillation (Afib). <a href="https://twitter.com/hashtag/HeartHealth?src=hashtag_click&quot; target="_blank">#HeartHealth</a> <a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a> <a href="https://twitter.com/Nick_Thaxton&quot; target="_blank">@Nick_Thaxton</a> <a href="https://twitter.com/jnoznesky&quot; target="_blank">@jnoznesky</a>

I had the opportunity today to speak to our professional education team, who delivers world-class education to physicians, HCPs, and <a href="https://twitter.com/AtriCure&quot; target="_blank">@AtriCure</a> teammates every day - ensuring that patients are treated safely and effectively. I'm so inspired by their commitment &amp; passion!

Our 2nd quarter earnings reflect strong growth worldwide and exceptional patient outcomes across all therapies, driving positive cash flow. We're advancing several clinical initiatives, introducing new products across our markets, &amp; improving efficiency.

Always inspired when meeting with our engineers to collaborate on innovations for our products, continuing our commitment to redefining post-op pain management. <a href="https://twitter.com/hashtag/cryoNB?src=hashtag_click&quot; target="_blank">#cryoNB</a>

Had the honor to speak virtually at the Asia-Pacific Ablation Summit! It was an incredible opportunity to connect with a packed room of physicians dedicated to advancing care for patients with <a href="https://twitter.com/hashtag/AFib.?src=hashtag_click" target="_blank">#AFib.</a> Grateful to be part of such an inspiring group. <a href="https://twitter.com/AtriCure_Asia&quot; target="_blank">@AtriCure_Asia</a>

For cardiac surgery patients, post-operative <a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a> (POAF) is one of the most common complications.​
​
Many of the classic cardiac risk factors can influence its development.​
​
To learn more about POAF risk factors, visit: <a href="https://t.co/YpFPtHwCts&quot; target="_blank">https://t.co/YpFPtHwCts</a&gt;
<a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

The term ‘Convergent Therapy’ goes beyond the physical meaning and extends to the people and ideas that come together. Dr. Zayd Eldadah explains what convergent therapy means and how cardiac surgeons and Eps join forces to make a greater impact.​

See the data:… <a href="https://t.co/c0AvStSvd7&quot; target="_blank">https://t.co/c0AvStSvd7</a&gt;

Dr. Joel Corvera was among the first in Indiana to use Cryo Nerve Block, making it a standard in his Thoracoabdominal aneurysm repairs. Since then, Dr. Coreva has gone on to treat 100 TAAA patients with <a href="https://twitter.com/hashtag/cryoNB.?src=hashtag_click" target="_blank">#cryoNB.</a> Congratulations, Dr. Coreva and <a href="https://twitter.com/IU_Health&quot; target="_blank">@IU_Health</a> team!

Learn more:… <a href="https://t.co/u8cd6kSOk3&quot; target="_blank">https://t.co/u8cd6kSOk3</a&gt;